Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: MRR

Insights on Global Microcarrier Market Size & Share Projected to Hit at USD 3,046.4 Billion and Rise at a CAGR of 10.4% By 2028: Industry Trends, Demand, Value, Analysis & Forecast Report | Zion Market Research


NEW YORK, May 24, 2022 /PRNewswire/ -- As per Zion Market Research study, The Microcarrier Market was worth around USD 1,682.6 million in 2021 and is estimated to grow to about USD 3,046.4 million by 2028, with a compound annual growth rate (CAGR) of approximately 10.4 percent over the forecast period. The report analyzes the Microcarrier Market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Microcarrier Market.

Zion Market Research Logo

Key Industry Insights & Finding of the Microcarrier Market Reports:

Zion Market Research published the latest report titled as  "Microcarrier Market By Product (Equipment, and Consumables. By Application (Vaccine Manufacturing, Cell Therapy, and Others). By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and CROs), And By Region ? Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 ? 2028." into their research database.

Microcarrier Market: Overview

Microcarriers help adherent cell development by acting as a support matrix. These microcarriers are placed in a bioreactor to aid in cell proliferation. The growing global disease burden has increased R&D activity with the goal of developing therapeutically effective drugs/vaccines, resulting in a need for microcarrier products. In addition, the growing requirement for therapeutically efficacious vaccines and pharmaceuticals is driving the worldwide microcarrier market, which has led to a growth in product demand for microcarriers. Many of the current biologics in development are aimed at indications that are dominated by small molecules and have a big patient pool. This implies that the biologics trend may infiltrate various non-traditional biologic disease areas during the projection period, benefiting from enhanced treatment efficacy. Furthermore, this creates space for the Microcarriers market to expand. Governments throughout the world are expanding their funding in various types of healthcare research and encouraging corporations to expand their R&D activities in order to harness breakthrough technology in cell therapy.

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/microbial-fermentation-technology-market

Our Free Sample Report Includes:

Industry Dynamics:

Microcarrier Market: Growth Dynamics

Drivers:  Increasing Interest in Cell-Based Vaccines and Therapeutics.

The need for cell-based vaccines is increasing, technologies are improving, and financing from private and public enterprises for cell-based research is driving the market for Microcarriers. Due to their importance in the vaccine production process, cell cultures are also expanding. Due to its shorter lead time and capacity to generate vaccinations in bigger numbers as needed, cell-based vaccines have emerged as a considerably more efficient way than others. Cell-based vaccinations have been shown in clinical trials to be as effective, efficacious, and safe as previous cell-based vaccines. Manufacturers have been attempting to boost their capability to improve their vaccines by increasing production output, which aids in cost reduction. As a result, immunizations are now available all over the world.

Restraints: The Expensiveness of Biologics and Cell-Based Therapies.

Microcarriers as well as Cell cultures are very expensive and involve a lot of R&D on any new medicines that come out. Small-scale businesses and academic institutions have limited funds and cannot always afford research. Furthermore, microcarriers always adhere to the cells, and the cells must be retrieved by a costly downstream process. These are the most significant challenges confronting the microcarrier market, and they are impeding growth. Moreover, the high expense of cell biology research and the scarcity of low-cost serum-free media are two factors that are expected to stymie industry expansion.

Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/microcarrier-market

Global Microcarrier Market: Segmentation

By Application, the market is classified into Vaccine Manufacturing, Cell Therapy, and Others. Over the forecast period, cell therapy is expected to show the most progress. Microcarriers aid in cost-effective cell production by lowering both fixed and variable costs during large-scale manufacture. The contemporary landscape has changed as a result of technical improvements, and the importance of microcarriers in cell treatment has grown. Since the microcarriers are totally dissolved, there is no need for separation, and the downstream process proceeds smoothly. As a result, these microcarriers are regarded as advantageous beads for large-scale cell manufacturing or cell treatment applications. Another element driving the expansion of cell therapy applications of microcarriers is that companies are now focusing on the provision of microcarriers that contribute to large-scale and cost-effective production.

By End User, the market is classified into Pharmaceutical and Biotechnology Companies, Research Institutes, and CROs. The pharmaceutical and biotechnology firms category is likely to dominate the microcarrier market. This is due to the increasing usage of single-use technologies in vaccine production and the expanding application areas of microcarriers. Due to the increasing demand for research and development in life-threatening diseases, the research institutes segment is expected to be the fastest expanding category. Microcarriers are used in a variety of research institutes to aid in patient health management. Demand for microcarriers is being created by innovation, discovery, and development in the microcarriers segment, which are assisting in making patient treatment more efficient.

Get More Insight before Buying@ : https://www.zionmarketresearch.com/inquiry/microcarrier-market

List of Key Players of Microcarrier Market:

Key questions answered in this report:

Report Scope:

Report Attribute

Details

Market size value in 2021

USD 1,682.6 Million

Revenue forecast in 2028

USD 3,046.4 Million

Growth Rate

CAGR of almost 10.4 % 2022-2028

Base Year

2020

Historic Years

2016 - 2021

Forecast Years

2022 - 2028

Segments Covered

By Product Type, By Application, and By End Use

Forecast Units

Value (USD Million), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2022 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Danaher Corporation, Corning Incorporated, Lonza, Becton, Dickinson and Company, Eppendorf AG, HiMedia Laboratories, and Sartorius AG.

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail customized purchase options to meet your exact research needs.  

https://www.zionmarketresearch.com/custom/3467

 Free Brochure: https://www.zionmarketresearch.com/requestbrochure/microcarrier-market

Recent Developments:

Regional Dominance:

During the projection period, North America dominated the global market. The region's leadership is due to increased R&D investments in cell and gene therapies, as well as the acceleration of vaccine development and production in the midst of the epidemic. In addition, the technological developments in company R&D led to increased utilization of microcarrier products. In addition, the United States is experiencing tremendous growth in the biologics and biosimilar industries, which is one of the primary drivers driving the microcarrier market in this area.

Additionally, Asia Pacific is expected to have a higher growth rate throughout the projection period due to an increase in chronic disease incidence, which would lead to increased investments in research such as stem cells, cell biology, and so on. The availability of research funds, technologically improved goods, and the strategic expansion of biopharmaceutical enterprises in this region are all factors driving market growth in this region. 

Global Microcarrier Market is segmented as follows:

Microcarrier Market: By Product Outlook (2022-2028)

Microcarrier Market: By Application Outlook (2022-2028)

Microcarrier Market: By End-User Outlook (2022-2028)

Microcarrier Market: By Region Outlook (2022-2028)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Press Release For Microcarrier Market: https://www.zionmarketresearch.com/news/global-microcarrier-market

Browse Other Related Research Reports from Zion Market Research

Browse through Zion Market Research's coverage of the Global Medical Device Industry

Follow Us on: LinkedIn | Twitter | Facebook

About Us

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us?after all?if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected] 
Website: https://www.zionmarketresearch.com/ 
Blog - https://zmrblog.com/

Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg


These press releases may also interest you

at 20:50
Overture.law, the nation's leading attorney-to-attorney referral platform, launches their transformative new product, Inner Circles. This groundbreaking product empowers attorneys, law schools, bar associations, and affinity groups to build private...

at 20:09
BASIS Charter Schools proudly announce that two of its exceptional students have been named 2024 U.S. Presidential Scholars by the U.S. Department of Education. Matteo N. Huish from BASIS Mesa and Sruti Peddi from BASIS Scottsdale have been...

at 20:00
Kemal Hawa, co-chair of the Digital Infrastructure, Data Center and Cloud Computing Practice of global law firm Greenberg Traurig, LLP, will moderate a panel at DICE East 2024 May 22 in Reston, Virginia. Hawa, a member of the firm's Washington,...

at 19:45
WIO LLC, parent company of the global TV broadcast airings platform, WIOprotm, has announced a new strategic agreement with Gracenote, the global content data business unit of Nielsen, to address the longstanding challenge of accurately tracking and...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...



News published on and distributed by: